Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |